November 2007 Briefing - Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for November 2007. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Botox-Seeking Patients Receive Quick Service
FRIDAY, Nov. 30 (HealthDay News) -- Dermatologists may offer shorter wait times to patients seeking cosmetic botulinum toxin injections than to those seeking urgent consultation for a changing mole, researchers report in the December issue of the Journal of the American Academy of Dermatology.
Parents, Peers Influence Teens' Indoor Tanning Habits
THURSDAY, Nov. 29 (HealthDay News) -- Parents -- and to a lesser extent peers -- play an important role in adolescent indoor tanning behavior, researchers report in the December issue of the Journal of the American Academy of Dermatology.
Pluripotent Stem Cells Created From Human Skin Cells
WEDNESDAY, Nov. 21 (HealthDay News) -- Researchers have successfully generated induced pluripotent stem cells from adult human fibroblasts, according to research published online Nov. 20 in Cell.
Smoking Linked to Male Hair Loss in Taiwanese Study
WEDNESDAY, Nov. 21 (HealthDay News) -- In a cross-sectional survey among Taiwanese men, smoking was linked to androgenetic alopecia, according to research published in the November issue of the Archives of Dermatology.
Outbreak in Laborers Linked to Flood-Damaged Huts
MONDAY, Nov. 19 (HealthDay News) -- A large proportion of construction workers working at a New Orleans military base developed a variety of skin outbreaks following hurricanes Katrina and Rita. The conditions are described in a report published in the November issue of the Archives of Dermatology.
FDA Seizes Potentially Harmful Eyelash Product
MONDAY, Nov. 19 (HealthDay News) -- At the request of the U.S. Food and Drug Administration, U.S. Marshals seized over 12,000 tubes of Age Intervention Eyelash this week, valued at over $2 million, due to concerns that the unapproved, drug-containing cosmetic could lead to decreased vision in some users.
Psychological Stress May Increase Skin Infection Severity
FRIDAY, Nov. 2 (HealthDay News) -- Psychological stress in mice reduces the ability of the epidermis to respond to infection by increased endogenous production of glucocorticoids, but this increased susceptibility can be normalized by blocking glucocorticoid production or administering topical lipids or both, researchers report in the November issue of the Journal of Clinical Investigation.
Antibiotic Worsens Amyotrophic Lateral Sclerosis
THURSDAY, Nov. 1 (HealthDay News) -- In patients with amyotrophic lateral sclerosis (ALS), minocycline leads to more rapid disease deterioration, reduced forced vital capacity and muscle strength, and higher mortality, according to a report published online Nov. 1 in The Lancet Neurology.